<p>, /PRNewswire/ -- 根据 MarketsandMarkets™的报告，<strong>血液学分析仪和试剂市场</strong> 预计将从 2026 年的约 75.7 亿美元增长到 2031 年的 103.3 亿美元，年均增长率为 6.4%。</p>
<p><strong>浏览 250 个市场数据表和 59 个图表，涵盖 300 页的详细目录，主题为'血液学分析仪和试剂市场 - 全球预测到 2031 年'</strong></p>
<p><strong>血液学分析仪和试剂市场规模及预测：</strong></p>
<ul>
<li><strong>可用市场规模年份：</strong> 2025–2031</li>
<li><strong>2026 年市场规模：</strong> 75.7 亿美元</li>
<li><strong>2031 年预计市场规模：</strong> 103.3 亿美元</li>
<li><strong>年均增长率（2026–2031）：</strong> 6.4%</li>
</ul>
<p><strong>血液学分析仪和试剂市场趋势与洞察：</strong></p>
<ul>
<li>血液学分析仪和试剂细分市场预计在 2025 年将占据最高市场份额，达到 60.5%。</li>
<li>中档血液学分析仪细分市场预计将注册最高的年均增长率，达到 6.3%。</li>
<li>血液癌症细分市场预计将在 2025 年占据 34% 的收入份额，主导市场。</li>
<li>亚太地区预计将在全球血液学分析仪和试剂市场中见证最高的年均增长率，达到 7.7%。</li>
</ul>
<p><strong>下载 PDF 手册 @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
<p>由于传统 CBC 测试的局限性，越来越多的趋势是使用先进的仪器和方法来诊断与血液相关的疾病，包括血液恶性肿瘤。与传统方法不同，这种创新技术不仅评估血细胞的基本特征，还评估其复杂特性，如形态。因此，可以更深入地了解血细胞群体的整体状况，包括识别异常细胞群体。</p>
<p><strong>血液产品和服务细分市场预计将在 2026–2031 年的预测期内注册显著的增长率。</strong></p>
<p>根据产品和服务，血液产品和服务细分市场预计将在 2025–2031 年的预测期内注册显著的增长率。血液学分析仪和试剂产品市场细分为血液产品和服务、免疫血液学产品和服务，以及止血产品和服务。</p>
<p>每个产品和服务细分市场进一步包括仪器、试剂、耗材和服务。推动血液产品和服务细分市场在预测期内增长的主要因素包括实验室自动化偏好的增加，如基于轨道的系统、中间件功能和自动验证，这些都提高了生产力并缩短了周转时间。此外，试剂和耗材的持续采购、由于血液相关疾病的流行而增加的测试数量，以及基于人工智能的决策系统的引入都在推动市场增长。</p>
<p><strong>请求样本页面 @</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
<p><strong>血液癌症细分市场预计将在预测期内占据血液学分析仪和试剂的最大份额。</strong></p>
<p>在应用细分市场中，血液癌症目前主导血液学分析仪和试剂市场，因为高度依赖常规的高精度血液测试。白血病、淋巴瘤、骨髓瘤和其他血液肿瘤需要定期测量细胞计数和分类，以及评估异常细胞，从而导致持续的高测试数量。早期诊断和疾病监测在很大程度上也依赖于更复杂的血液学测试技术和参数。全球血液癌症的发病率不断上升将进一步巩固其在市场中的地位。</p>
<p><strong>亚太地区预计将在预测期内注册市场最高的年均增长率。</strong></p>
<p>在 2025 年，亚太地区预计将在血液学分析仪和试剂市场中注册最高的年均增长率。亚太地区包括中国、印度、韩国、台湾和新加坡，以及亚太地区的其他国家。传染病和慢性疾病的发生率增加，加上患者数量的增长，将推动对诊断测试的需求。其他可能促进市场增长的重要因素包括健康服务的可用性增加、私营诊断实验室的增长、使用高效和经济的分析仪，以及对早期疾病检测的认识提高。此外，技术的进步，如适用于资源有限环境的便携式和即时检测（POC）血液学分析仪，将进一步推动市场增长。</p>
<p><strong>购买前咨询 @</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
<p><strong>血液学分析仪和试剂市场的顶级公司：</strong></p>
<p>血液学分析仪和试剂市场的顶级公司包括 Sysmex Corporation（日本）、Danaher Corporation（美国）、Nihon Kohden Corporation（日本）、Siemens Healthineers（德国）、Abbott Laboratories（美国）、Boule Diagnostics AB（瑞典）、Horiba, Ltd.（日本）、Bio-Rad Laboratories Inc.（美国）、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（中国）和 F. Hoffmann-La Roche Ltd.（瑞士）等。</p>
<p><strong>浏览相关市场</strong>：<strong>医疗设备市场研究</strong> <strong>报告与咨询</strong></p>
<p><strong>相关报告：</strong></p>
<p><strong>体外诊断市场</strong> <strong>- 全球预测到 2030 年</strong></p>
<p><strong>即时检测市场</strong> <strong>- 全球预测到 2029 年</strong></p>
<p><strong>凝血分析仪市场</strong> <strong>- 全球预测到 2030 年</strong></p>
<p><strong>临床化学分析仪市场</strong> <strong>- 全球预测到 2030 年</strong></p>
<p><strong>IVD 试剂市场</strong> <strong>- 全球预测到 2029 年</strong></p>
<p><strong>关于 MarketsandMarkets™</strong></p>
<p>MarketsandMarkets™被《福布斯》评选为美国最佳管理咨询公司之一，依据其最新报告。</p>
<p>MarketsandMarkets™ 是增长咨询和项目管理领域的蓝海替代方案，利用人机结合的服务推动 B2B 领域进步组织的超常增长。我们以最广泛的视角关注新兴技术，擅长为全球客户共同创造超常增长。</p>
<p>如今，80% 的财富 2000 强公司依赖于 MarketsandMarkets，且每个行业前 100 家公司中有 90 家信任我们以加速其收入增长。我们拥有超过 13,000 家组织的全球客户群，帮助企业在颠覆性生态系统中蓬勃发展。</p>
<p>B2B 经济正在见证 25 万亿美元新收入来源的出现，这些收入将在本十年内取代现有的收入来源。我们与客户合作开展增长项目，帮助他们通过我们的服务线——市场总量扩展、市场进入（GTM）战略到执行、市场份额提升、客户赋能和思想领导力营销，来实现这一 25 万亿美元的机会。</p>
<p>基于 “GIVE Growth” 原则，我们与多家《福布斯》全球 2000 强 B2B 公司合作，帮助他们保持未来准备。我们的洞察和战略由行业专家、尖端人工智能和我们的市场情报云平台 KnowledgeStore™提供支持，整合研究并提供生态系统范围内的收入变化可视化。</p>
<p>MarketsandMarkets™ SalesPlay 是一款基于人工智能的收入智能助手，旨在帮助收入团队优先处理合适的客户，及早识别关键变化，并在需求之前发现机会，从而自然构建销售管道，并以更高的一致性完成交易。</p>
<p>欲了解更多信息，请访问 www.MarketsandMarkets™.com 或在 Twitter、LinkedIn 和 Facebook 上关注我们。</p>
<p>联系方式：</p>
<p>罗汉·萨尔加卡尔（Mr. Rohan Salgarkar）</p>
<p>MarketsandMarkets™ INC.</p>
<p>南国会大街 1615 号（1615 South Congress Ave.）</p>
<p>103 套房，德尔雷海滩，佛罗里达州 33445（Suite 103, Delray Beach, FL 33445）</p>
<p>美国电话：+1-888-600-6441</p>
<p>电子邮件：[email protected]</p>
<p>访问我们的网站：https://www.marketsandmarkets.com/</p>
<p>标志：https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
<p>来源 MarketsandMarkets</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw"/></p>

6869

希森美康(ADR)

丹纳赫

<p>血液学分析仪和试剂市场预计将从 2026 年的 75.7 亿美元增长到 2031 年的 103.3 亿美元，年均增长率为 6.4%。亚太地区预计将见证最高的增长率，主要受对先进诊断工具需求增加和血液相关疾病发病率上升的推动。血癌细分市场预计将在 2025 年占据市场主导地位，收入份额达到 34%。主要参与者包括希森美康（Sysmex Corporation）、丹纳赫（Danaher Corporation）和西门子医疗（Siemens Healthineers）</p>

<p>, /PRNewswire/ -- According to MarketsandMarkets™, the <strong>Hematology Analyzers and Reagents Market</strong> is projected to grow from about USD 7.57 billion in 2026 to USD 10.33 billion by 2031, at a CAGR of 6.4%.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 根据 MarketsandMarkets™的报告，<strong>血液学分析仪和试剂市场</strong> 预计将从 2026 年的约 75.7 亿美元增长到 2031 年的 103.3 亿美元，年均增长率为 6.4%。</p>
</div><p><strong>Browse 250 market data Tables and 59 Figures spread through 300 Pages and in-depth TOC on 'Hematology Analyzers and Reagents Market - Global Forecast to 2031'</strong></p>
<div class="lb-trans"><p><strong>浏览 250 个市场数据表和 59 个图表，涵盖 300 页的详细目录，主题为'血液学分析仪和试剂市场 - 全球预测到 2031 年'</strong></p>
</div><p><strong>Hematology Analyzers and Reagents Market Size &amp; Forecast:</strong></p>
<div class="lb-trans"><p><strong>血液学分析仪和试剂市场规模及预测：</strong></p>
</div><ul>
<li><strong>Market Size Available for Years:</strong> 2025–2031</li>
<li><strong>2026 Market Size:</strong> USD 7.57 billion</li>
<li><strong>2031 Projected Market Size:</strong> USD 10.33 billion</li>
<li><strong>CAGR (2026–2031):</strong> 6.4%</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>可用市场规模年份：</strong> 2025–2031</li>
<li><strong>2026 年市场规模：</strong> 75.7 亿美元</li>
<li><strong>2031 年预计市场规模：</strong> 103.3 亿美元</li>
<li><strong>年均增长率（2026–2031）：</strong> 6.4%</li>
</ul>
</div><p><strong>Hematology Analyzers and Reagents Market Trends &amp; Insights:</strong></p>
<div class="lb-trans"><p><strong>血液学分析仪和试剂市场趋势与洞察：</strong></p>
</div><ul>
<li>The hematology analyzers &amp; reagents segment is estimated to account for the highest market share of 60.5% in 2025.</li>
<li>The mid-range hematology analyzers segment is expected to register the highest CAGR of 6.3%.</li>
<li>The blood cancer segment is expected to dominate the market with 34% revenue share in 2025.</li>
<li>The Asia Pacific region is projected to witness the highest CAGR of 7.7% in the global hematology analyzers &amp; reagents market.</li>
</ul>
<div class="lb-trans"><ul>
<li>血液学分析仪和试剂细分市场预计在 2025 年将占据最高市场份额，达到 60.5%。</li>
<li>中档血液学分析仪细分市场预计将注册最高的年均增长率，达到 6.3%。</li>
<li>血液癌症细分市场预计将在 2025 年占据 34% 的收入份额，主导市场。</li>
<li>亚太地区预计将在全球血液学分析仪和试剂市场中见证最高的年均增长率，达到 7.7%。</li>
</ul>
</div><p><strong>Download PDF Brochure @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>下载 PDF 手册 @</strong> https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146</p>
</div><p>There is an increasing trend toward using advanced instruments and methods to diagnose blood-associated disorders, including hematological malignancies, due to the limitations of the traditional CBC test. Unlike conventional approaches, this innovative technology evaluates not only the basic characteristics of blood cells but also their complex properties, such as morphology. As a result, deeper insight into the overall condition of blood cell populations is possible, including the identification of abnormal cell populations.</p>
<div class="lb-trans"><p>由于传统 CBC 测试的局限性，越来越多的趋势是使用先进的仪器和方法来诊断与血液相关的疾病，包括血液恶性肿瘤。与传统方法不同，这种创新技术不仅评估血细胞的基本特征，还评估其复杂特性，如形态。因此，可以更深入地了解血细胞群体的整体状况，包括识别异常细胞群体。</p>
</div><p><strong>The hematology products &amp; services segment is expected to register a significant growth rate over the forecast period of 2026–2031.</strong></p>
<div class="lb-trans"><p><strong>血液产品和服务细分市场预计将在 2026–2031 年的预测期内注册显著的增长率。</strong></p>
</div><p>Based on the product and service, the hematology products &amp; services segment is expected to register a significant growth rate over the forecast period of 2025–2031. The hematology analyzers and reagents product market is segmented into hematology products &amp; services, immunohematology products &amp; services, and hemostasis products &amp; services.</p>
<div class="lb-trans"><p>根据产品和服务，血液产品和服务细分市场预计将在 2025–2031 年的预测期内注册显著的增长率。血液学分析仪和试剂产品市场细分为血液产品和服务、免疫血液学产品和服务，以及止血产品和服务。</p>
</div><p>Each of the product &amp; service segments further comprises instruments, reagents, consumables, and services. The primary driving factors for the growth of the hematology products and services segment over the forecast period include the rise in automation preferences in laboratories, such as track-based systems, middleware capabilities, and auto-validation, which result in increased productivity and shorter turnaround times. Moreover, the continuous purchase of reagents and consumables, an increase in the number of tests due to the rising prevalence of blood-related diseases, and the incorporation of artificial intelligence-based decision-making systems are contributing to market growth.</p>
<div class="lb-trans"><p>每个产品和服务细分市场进一步包括仪器、试剂、耗材和服务。推动血液产品和服务细分市场在预测期内增长的主要因素包括实验室自动化偏好的增加，如基于轨道的系统、中间件功能和自动验证，这些都提高了生产力并缩短了周转时间。此外，试剂和耗材的持续采购、由于血液相关疾病的流行而增加的测试数量，以及基于人工智能的决策系统的引入都在推动市场增长。</p>
</div><p><strong>Request Sample Pages@</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>请求样本页面 @</strong> https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146</p>
</div><p><strong>The blood cancer segment is projected to account for the largest share of hematology analyzers and reagents during the forecast period.</strong></p>
<div class="lb-trans"><p><strong>血液癌症细分市场预计将在预测期内占据血液学分析仪和试剂的最大份额。</strong></p>
</div><p>In the application segment, blood cancer currently dominates the hematology analyzers and reagents market due to the high dependence on routine, highly accurate blood tests. Leukemia, lymphomas, myelomas, and other hematological cancers require regular measurement of cell counts and differentials, as well as assessment of abnormal cells, resulting in a sustained high number of tests. Early diagnosis and monitoring of diseases also largely depend on more sophisticated techniques for hematology testing and parameters. The increasing prevalence rates of hematological cancers all over the world will only solidify their position in the market.</p>
<div class="lb-trans"><p>在应用细分市场中，血液癌症目前主导血液学分析仪和试剂市场，因为高度依赖常规的高精度血液测试。白血病、淋巴瘤、骨髓瘤和其他血液肿瘤需要定期测量细胞计数和分类，以及评估异常细胞，从而导致持续的高测试数量。早期诊断和疾病监测在很大程度上也依赖于更复杂的血液学测试技术和参数。全球血液癌症的发病率不断上升将进一步巩固其在市场中的地位。</p>
</div><p><strong>Asia Pacific is projected to register the highest CAGR in the market during the forecast period.</strong></p>
<div class="lb-trans"><p><strong>亚太地区预计将在预测期内注册市场最高的年均增长率。</strong></p>
</div><p>In 2025, Asia Pacific is projected to register the highest CAGR in the market for hematology analyzers and reagents during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. An increase in the incidence of infectious and chronic diseases, along with a growing number of patients, will drive demand for diagnostic tests. Other important factors likely to contribute to the growth of the market include increased availability of health services, growth of private diagnostic labs, use of efficient and economical analyzers, and heightened awareness of early disease detection. Moreover, advances in technology, such as portable and point-of-care (POC) hematology analyzers for resource-limited environments, will further fuel market growth.</p>
<div class="lb-trans"><p>在 2025 年，亚太地区预计将在血液学分析仪和试剂市场中注册最高的年均增长率。亚太地区包括中国、印度、韩国、台湾和新加坡，以及亚太地区的其他国家。传染病和慢性疾病的发生率增加，加上患者数量的增长，将推动对诊断测试的需求。其他可能促进市场增长的重要因素包括健康服务的可用性增加、私营诊断实验室的增长、使用高效和经济的分析仪，以及对早期疾病检测的认识提高。此外，技术的进步，如适用于资源有限环境的便携式和即时检测（POC）血液学分析仪，将进一步推动市场增长。</p>
</div><p><strong>Inquire Before Buying@</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
<div class="lb-trans"><p><strong>购买前咨询 @</strong> https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=153222146</p>
</div><p><strong>Top Companies in Hematology Analyzers and Reagents Market:</strong></p>
<div class="lb-trans"><p><strong>血液学分析仪和试剂市场的顶级公司：</strong></p>
</div><p>The Top Companies in Hematology Analyzers and Reagents Market include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.</p>
<div class="lb-trans"><p>血液学分析仪和试剂市场的顶级公司包括 Sysmex Corporation（日本）、Danaher Corporation（美国）、Nihon Kohden Corporation（日本）、Siemens Healthineers（德国）、Abbott Laboratories（美国）、Boule Diagnostics AB（瑞典）、Horiba, Ltd.（日本）、Bio-Rad Laboratories Inc.（美国）、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（中国）和 F. Hoffmann-La Roche Ltd.（瑞士）等。</p>
</div><p><strong>Browse Adjacent Markets</strong>: <strong>Medical Devices Market Research</strong> <strong>Reports &amp; Consulting</strong></p>
<div class="lb-trans"><p><strong>浏览相关市场</strong>：<strong>医疗设备市场研究</strong> <strong>报告与咨询</strong></p>
</div><p><strong>Related Reports:</strong></p>
<div class="lb-trans"><p><strong>相关报告：</strong></p>
</div><p><strong>In Vitro Diagnostics Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>体外诊断市场</strong> <strong>- 全球预测到 2030 年</strong></p>
</div><p><strong>Point of Care Diagnostics Market</strong> <strong>- Global Forecast to 2029</strong></p>
<div class="lb-trans"><p><strong>即时检测市场</strong> <strong>- 全球预测到 2029 年</strong></p>
</div><p><strong>Coagulation Analyzer Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>凝血分析仪市场</strong> <strong>- 全球预测到 2030 年</strong></p>
</div><p><strong>Clinical Chemistry Analyzers Market</strong> <strong>- Global Forecast to 2030</strong></p>
<div class="lb-trans"><p><strong>临床化学分析仪市场</strong> <strong>- 全球预测到 2030 年</strong></p>
</div><p><strong>IVD Reagents Market</strong> <strong>- Global Forecast to 2029</strong></p>
<div class="lb-trans"><p><strong>IVD 试剂市场</strong> <strong>- 全球预测到 2029 年</strong></p>
</div><p><strong>About MarketsandMarkets™</strong></p>
<div class="lb-trans"><p><strong>关于 MarketsandMarkets™</strong></p>
</div><p>MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.</p>
<div class="lb-trans"><p>MarketsandMarkets™被《福布斯》评选为美国最佳管理咨询公司之一，依据其最新报告。</p>
</div><p>MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.</p>
<div class="lb-trans"><p>MarketsandMarkets™ 是增长咨询和项目管理领域的蓝海替代方案，利用人机结合的服务推动 B2B 领域进步组织的超常增长。我们以最广泛的视角关注新兴技术，擅长为全球客户共同创造超常增长。</p>
</div><p>Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.</p>
<div class="lb-trans"><p>如今，80% 的财富 2000 强公司依赖于 MarketsandMarkets，且每个行业前 100 家公司中有 90 家信任我们以加速其收入增长。我们拥有超过 13,000 家组织的全球客户群，帮助企业在颠覆性生态系统中蓬勃发展。</p>
</div><p>The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.</p>
<div class="lb-trans"><p>B2B 经济正在见证 25 万亿美元新收入来源的出现，这些收入将在本十年内取代现有的收入来源。我们与客户合作开展增长项目，帮助他们通过我们的服务线——市场总量扩展、市场进入（GTM）战略到执行、市场份额提升、客户赋能和思想领导力营销，来实现这一 25 万亿美元的机会。</p>
</div><p>Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.</p>
<div class="lb-trans"><p>基于 “GIVE Growth” 原则，我们与多家《福布斯》全球 2000 强 B2B 公司合作，帮助他们保持未来准备。我们的洞察和战略由行业专家、尖端人工智能和我们的市场情报云平台 KnowledgeStore™提供支持，整合研究并提供生态系统范围内的收入变化可视化。</p>
</div><p>MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.</p>
<div class="lb-trans"><p>MarketsandMarkets™ SalesPlay 是一款基于人工智能的收入智能助手，旨在帮助收入团队优先处理合适的客户，及早识别关键变化，并在需求之前发现机会，从而自然构建销售管道，并以更高的一致性完成交易。</p>
</div><p>To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 www.MarketsandMarkets™.com 或在 Twitter、LinkedIn 和 Facebook 上关注我们。</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Mr. Rohan Salgarkar</p>
<div class="lb-trans"><p>罗汉·萨尔加卡尔（Mr. Rohan Salgarkar）</p>
</div><p>MarketsandMarkets™ INC.</p>
<div class="lb-trans"><p>MarketsandMarkets™ INC.</p>
</div><p>1615 South Congress Ave.</p>
<div class="lb-trans"><p>南国会大街 1615 号（1615 South Congress Ave.）</p>
</div><p>Suite 103, Delray Beach, FL 33445</p>
<div class="lb-trans"><p>103 套房，德尔雷海滩，佛罗里达州 33445（Suite 103, Delray Beach, FL 33445）</p>
</div><p>USA: +1-888-600-6441</p>
<div class="lb-trans"><p>美国电话：+1-888-600-6441</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>Visit Our Website: https://www.marketsandmarkets.com/</p>
<div class="lb-trans"><p>访问我们的网站：https://www.marketsandmarkets.com/</p>
</div><p>Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
<div class="lb-trans"><p>标志：https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg</p>
</div><p>SOURCE MarketsandMarkets</p>
<div class="lb-trans"><p>来源 MarketsandMarkets</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9SU81NzI2MCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIxMDE1UFJfTkVXU19VU1BSX19fX19JTzU3MjYw" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=IO57260&amp;Transmission_Id=202605121015PR_NEWS_USPR_____IO57260&amp;DateId=20260512"/></p>

ETHematology 分析仪和试剂市场预计到 2031 年将达到 103.3 亿美元 | MarketsandMarkets™